Pregnancy raises real questions about safety when someone is using alcohol, opioids, stimulants, benzodiazepines, cannabis, or tobacco. Specialized medical care matters because treatment choices affect both the pregnant person and the developing fetus. This article explains common risks, evidence-based options, and how clinicians make individualized decisions.

Why specialized care matters for pregnancy substance use treatment safety

Caring for substance use in pregnancy combines addiction medicine, obstetrics, pediatrics, and behavioral health. For example, for opioid use disorder (OUD) the recommended standard of care is medication for opioid use disorder, paired with prenatal care and behavioral therapies, which reduces overdose, improves prenatal engagement, and improves outcomes for mother and infant. National guidance supports offering methadone or buprenorphine rather than abrupt detox in most cases. SAMHSA clinical guidance, CDC pregnancy substance use resources, and NIDA summaries describe these approaches and their rationale.

Key principles clinicians follow

  • Screen routinely with validated tools, then offer nonjudgmental care and referrals. ACOG guidance.
  • Prioritize treatments that reduce immediate risks to the parent, such as overdose or severe withdrawal, while minimizing fetal harm. SAMHSA clinical guidance.
  • Tailor choices to the substance, pattern of use, gestational age, medical comorbidity, and patient preferences – placement and medication decisions require assessment by a qualified clinician.
Safety note: If you are in immediate danger, call 911. If you or someone you know is having a mental health or suicide crisis, call or text 988 for the 988 Suicide & Crisis Lifeline. For emergencies related to intoxication, overdose, severe withdrawal, seizures, or psychosis, seek urgent medical care or call 911.

Common substances and typical clinical approaches

The table below summarizes common substances, pregnancy risks, and typical evidence-based treatment approaches used in specialized programs. Clinical teams will individualize care; this table is a high level comparison, not advice for an individual case.

Substance Pregnancy risks Usual treatment approach in pregnancy
Opioids (heroin, prescription opioids) Risk of overdose, neonatal opioid withdrawal, preterm birth, stillbirth in untreated OUD Medication for OUD (methadone or buprenorphine), prenatal monitoring, behavioral therapy; avoid abrupt detox unless under specialty supervision. CDC, SAMHSA
Alcohol Miscarriage, stillbirth, fetal alcohol spectrum disorders; no known safe amount. Counsel to stop drinking; for moderate to severe dependence, medically supervised withdrawal and obstetric monitoring in consultation with addiction specialists. CDC
Benzodiazepines Possible neonatal withdrawal, floppy infant at delivery if taken close to birth Avoid abrupt cessation; consider slow taper or substitution to a longer-acting agent under medical supervision, may need inpatient management. Guidelines
Stimulants (methamphetamine, cocaine) Preterm birth, low birth weight, placental problems Behavioral treatments including contingency management and CBT are primary options; refer to specialist for pharmacologic questions. Clinical review
Cannabis Possible preterm birth, low birth weight, and developmental concerns Recommend cessation, use behavioral counseling and supportive services; no medical indication for cannabis in pregnancy. ACOG
Tobacco and nicotine Premature birth, low birth weight, placental problems Behavioral counseling; consider nicotine replacement therapy when counseling alone fails, under clinician oversight. SAMHSA

What specialized programs provide

Outpatient pregnancy-focused programs provide coordinated care that may include:

  • Medication management for OUD (methadone or buprenorphine) with obstetric coordination. NIDA review.
  • Behavioral therapies such as cognitive behavioral therapy, motivational interviewing, and contingency management for stimulant, cannabis, alcohol, or tobacco use. Clinical review.
  • Care navigation for prenatal appointments, social needs, and community resources.
  • Planning for delivery, newborn monitoring for withdrawal, and postpartum support including breastfeeding guidance when appropriate. Expert protocols support breastfeeding for parents on stable methadone or buprenorphine with close follow-up. Academy of Breastfeeding Medicine.

Why not just detox at any time?

For many substances, especially opioids and alcohol, abrupt cessation without medical supervision can be harmful. For opioid use disorder, stopping medication treatment during pregnancy raises the risk of relapse and overdose, which can be fatal for the parent and harmful for the fetus. National guidance recommends continuing or initiating methadone or buprenorphine rather than routine detox for OUD. SAMHSA, CDC.

Legal and privacy considerations in New Jersey

New Jersey policy emphasizes voluntary, supportive care. A positive screening test alone is not automatically evidence of child abuse, and follow-up biologic testing should only be done with informed consent; hospitals and birth centers are advised to develop policies that avoid unnecessary punitive responses and connect families with services. Specialized programs coordinate with local obstetric and pediatric teams while observing state reporting requirements. For New Jersey specific guidance, see the New Jersey Department of Health memorandum. New Jersey Department of Health guidance.

Frequently asked questions

Is medication-assisted treatment safe during pregnancy?

Methadone and buprenorphine are considered standard treatments for OUD in pregnancy, and when used with prenatal care they reduce overdose risk and support better engagement with care. Neonatal opioid withdrawal can occur, but it is treatable and the benefits of medication treatment for the pregnant person typically outweigh the risks of untreated OUD. NIDA, CDC.

Will I lose custody if a drug test is positive at delivery?

Policies vary, but New Jersey guidance emphasizes offering services and using confirmatory testing rather than automatic punitive action. Discuss testing and reporting with your prenatal team, and ask about programs that provide support for parents and infants. NJ Department of Health.

Can I breastfeed if I am on methadone or buprenorphine?

Specialty guidance generally supports breastfeeding for parents who are stable on methadone or buprenorphine and who are not using illicit drugs, with appropriate monitoring for the newborn. Discuss breastfeeding plans with your pediatrician and addiction provider. Academy of Breastfeeding Medicine.

Next steps and how specialized outpatient care can help

If you are pregnant and using substances, the safest first step is to connect with a program that coordinates obstetric care and addiction treatment. A qualified clinician will assess medical history, the type and severity of substance use, pregnancy stage, mental health, and social supports to make individualized recommendations. For information about treatment types and services our center offers, see our treatments page, find a convenient location, or contact us for confidential information.

Specialized outpatient programs can help you access medication when indicated, behavioral therapies, prenatal coordination, care navigation, and support for parenting and breastfeeding when appropriate. They also link patients to hospital teams for delivery planning and newborn monitoring.

Sources

Compassionate invitation

If you are thinking about treatment, a confidential clinical assessment can clarify options and safety for you and your baby. Call or request a confidential assessment, or speak with our admissions team to learn about outpatient supports, medication options, and prenatal coordination. We do not guarantee admission or outcomes, but we will provide honest, evidence-based information and help you take the next step when you are ready.